Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

GDC-2992

🥰Excellent
Catalog No. T204088Cas No. 2753651-10-2
Alias RO7656594, RO 7656594, GDC2992

GDC-2992 is a selective and orally active androgen receptor (AR) degradator that degrades AR (DC50 = 2.7 nM) and inhibits proliferation (IC50 = 9.7 nM) in VCaP cells, making it suitable for studying castration-resistant prostate cancer (CRPC).

GDC-2992

GDC-2992

🥰Excellent
Catalog No. T204088Alias RO7656594, RO 7656594, GDC2992Cas No. 2753651-10-2
GDC-2992 is a selective and orally active androgen receptor (AR) degradator that degrades AR (DC50 = 2.7 nM) and inhibits proliferation (IC50 = 9.7 nM) in VCaP cells, making it suitable for studying castration-resistant prostate cancer (CRPC).
Pack SizePriceAvailabilityQuantity
1 mg$339In Stock
5 mg$793In Stock
10 mg$1,320In Stock
25 mg$2,530In Stock
50 mg$4,150In Stock
Add to Cart
Add to Quotation
Bulk & Custom
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
View More

Resource Download

Product Introduction

Bioactivity
Description
GDC-2992 is a selective and orally active androgen receptor (AR) degradator that degrades AR (DC50 = 2.7 nM) and inhibits proliferation (IC50 = 9.7 nM) in VCaP cells, making it suitable for studying castration-resistant prostate cancer (CRPC).
Targets&IC50
EGFR (L858R):1.1  nM, EGFR (WT): 5.6 nM
In vitro
GDC-2992 exhibits potent inhibitory activity against multiple EGFR mutations, particularly EGFR L858R and T790M/L858R, with IC₅₀ values of 1.1 nM and 1.0 nM, respectively. In the H1975 lung cancer cell line (harboring the T790M/L858R mutation), it inhibits cell proliferation with an IC₅₀ of 5.6 nM and effectively suppresses phosphorylation of downstream signaling proteins including p-EGFR, p-AKT, and p-ERK. GDC-2992 shows weak inhibition of wild-type EGFR (IC₅₀ > 100 nM), indicating strong selectivity for mutant forms[1].
In vivo
In NSG mice bearing H1975 xenograft tumors, GDC-2992 administered orally once daily (QD) demonstrated dose-dependent antitumor activity, achieving near-complete tumor regression at 100 mg/kg. The compound significantly reduced p-EGFR levels in tumor tissue, confirming effective target engagement in vivo[1].
AliasRO7656594, RO 7656594, GDC2992
Chemical Properties
Molecular Weight819.39
FormulaC45H51ClN8O5
Cas No.2753651-10-2
SmilesO([C@H]1C(C)(C)[C@H](NC(=O)C2=CC=C(C=C2)N3CCC(CN4CCN(CC4)C=5C=C6C(=CC5)C(=O)N(N=C6)[C@@H]7C(=O)NC(=O)CC7)CC3)C1(C)C)C8=CC(Cl)=C(C#N)C=C8
Relative Density.no data available
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 30 mg/mL (36.61 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.2204 mL6.1021 mL12.2042 mL61.0210 mL
5 mM0.2441 mL1.2204 mL2.4408 mL12.2042 mL
10 mM0.1220 mL0.6102 mL1.2204 mL6.1021 mL
20 mM0.0610 mL0.3051 mL0.6102 mL3.0511 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Sci Citations

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy GDC-2992 | purchase GDC-2992 | GDC-2992 cost | order GDC-2992 | GDC-2992 chemical structure | GDC-2992 in vivo | GDC-2992 in vitro | GDC-2992 formula | GDC-2992 molecular weight